Interferon-α enhances the sensitivity of human osteosarcoma cells to etoposide

Journal of Interferon and Cytokine Research

Volumn 19, Issue 6, 1999, Pages 617-624

  Jia, Shu Fang ^a   An, Taeha ^a   Worth, Laura ^a   Kleinerman, Eugenie S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMSACRINE; CISPLATIN; DACTINOMYCIN; DIMETHYL SULFOXIDE; DNA TOPOISOMERASE (ATP HYDROLYSING); DODECYL SULFATE SODIUM; DOXORUBICIN; ETOPOSIDE; POTASSIUM CHLORIDE; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CYCLE; CELL SURVIVAL; COLONY FORMATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DNA SYNTHESIS; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG UPTAKE; HUMAN; HUMAN CELL; IMMUNOREGULATION; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL CYCLE; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ETOPOSIDE; HUMANS; INTERFERON-ALPHA; OSTEOSARCOMA; TUMOR CELLS, CULTURED;

ILEX COOKII;

EID: 0032814630     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313758     Document Type: Article

References (33)

1. JAFFE, N. (1986). Chemotherapy in osteosarcoma: advances and controversies. In: Experimental and Clinical Progress in Chemo- therapy. P.M. Muggia (ed.) Boston: Martinus Nijhof Publishers, pp. 223-244.
2. LINK, M.R. GOORIN, A.M., MISER, A.W., GREEN, A.A., PRATT, C.B., BELASCO, J.B. PRITCHARD, J., MALPAS, J.S., BAKEER, A.R., KIRKPATRICK, J.A., AYALA, A.G., SHUSTER, J.J., ABELSON, U.T., SIMONE, J.V., and VIETTI, T.J. (1986). The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of extremity. N. Engl. J. Med. 314, 1600-1606.
3. EIBER, F., GIULIANO, A., ECHARDT, J., PATTERSON, K., MOSELEY, S., and GOODNIGHT, J. (1987). Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J. Clin. Oncol. 5, 21-26.
4. GOORIN, A.M., SHUSTER, J.J., BAKER, A., HOROWITZ, M.E., MEYER, W.H., and LINK, M.P. (1991). Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multi-institutional osteosarcoma study. J. Clin. Oncol. 9, 6000-6005.
5. HARRIS, M.B., CANTOR, A.B., GOORIN, A.M., SHACHAT, S.J., AYALA, A.C., FERGUSON, W.S., HOLBROOK, T., and LINK, M.P. (1995). Treatment of osteosarcoma with ifosfamide: Comparison of response in pediatric patients with recurrent disease versus patients previously untreated. A Pediatric Oncology Group study. Med. Ped. Oncol. 24, 87-92.
6. McLEOD, G.R.C., THOMSON, D.B., and HERSEY, P. (1987). Recombinant interferon alfa-2a in advanced malignant melanoma, a phase I-II study in combination with DTIC. Int. J. Cancer (Suppl.) 1, 31-35.
7. BAJETTA, E., NEGRETTI, E., GIANNOTTI, B., BROGELLI, L., BRUNETT, I., SERTOLI, M.R., BERNENGO, M.G., SOFRA, M.C., MAIFREDI, G., and ZUMIANI, G. (1990). Phase II study of interferon α-2a and dacarbazine in advanced melanoma. Amer. J. Cin Oncol. 13, 405-409.
8. FALKSON, C.I., FALKSON, G., and FALKSON, H.C. (1991). Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma. J. Clin. Oncol. 9, 1403-1408.
9. BUZAID, A.C., and LEGHA, S.S. (1994). Combination of chemotherapy with interleukin-2 and interferon alpha for the treatment of advanced melanoma. Semin. Oncol. 21 (6 Suppl. 14), 23-28.
10. LAUTA, V.M. (1995). Update on the use of interferons in clinical practice. Clinica Terapeutica 146, 393-448.
11. RAGNHAMMAR, P., BLOMGREN, H., EDLER, D., LUNDELL, G., MAGNUSSON, I., and SONNENFELD, T. (1995). Different dose regimens of 5-fluorouracil and interferon alpha in patients with colorectal carcinoma. Eur. J. Cancer 31A, 315-320.
12. HASSAN, H.T., GRELL, S., BORRMANN-DANSO, U., and FREUND, M. (1996). Interferon-α enhances the cytotoxic and cytostatic activities of chemotherapeutic drugs in human myeloid leukemia cells. J. Interferon Cytokine Res. 16, 139-146.
13. HASSAN, H.T., and MAURER, H.R. (1992). Synergism between recombinant human interferon-alpha and carboplatin in inhibiting K562 human myloid leukemia colonogenic cells: new potential therapeutic development. Leuk. Res. 16, 419-420.
14. VON HOFF, D.D. (1991). In vitro data supporting interferon plus cytotoxic agent combination. Semin. Oncol. 18 (Suppl. 7), 58-61.
15. WADLER, S., and SCHWARTZ, E.L. (1990). Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review. Cancer Res 50, 3473-3486.
16. EINHORN, S., and STRANDER, H. (1978). Interferon therapy for neoplastic disease in man in vitro and in vivo studies. Adv. Exp. Med. Biol. 110, 159-174.
17. STRANDER. H., BAUER, H.C.F., BROSJO, O., KREICBERGS, A., LINDHOLM, J., NILSONNE, U., SILFVERSWARD, C., and SZAMOSI, A. (1993). Adjuvant interferon treatment in human osteosarcoma. In: Osteosarcoma in Adolescents and Young Adults. G.B. Humphrey (ed.). Boston; Kluwer Academic Publishers, pp. 29-32.
18. AGARWALA, S.S., and KIRKWOOD, J.M. (1995). Potential uses of interferon α2 as adjuvant therapy in cancer. Ann. Surg. Oncol. 2, 365-371.
19. CAPARROS, B., ROSEN, G., and CUNNINGHAM-RUNDLES, S. (1982). Phase II trial of interferon on metastatic osteogenic sarcoma. Proc. Am. Assoc. Cancer. 23, 121.
20. HOMMA, Y., and ASO, Y. (1994). Effect of alpha-interferon alone and combined with other antineoplastic agents on renal cell carcinoma determined by the tetrazolium microculture assay. Eur. Urol. 25, 164-170.
21. HAND, A., PELIN, K., HALME, M., EKMAN, A., MATTSON, M., VALLAS, M., MATTSON, K., LINNAINMAA, K., and HUSGAFVEL-PURSIAINEN, K. (1993). Interferon-alpha and interferon gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines. Anti-Cancer Drugs 4, 365-368.
22. BLETRY, O., and PAPO, T. (1993). Interferons. Interferon's alpha and gamma: Indications in systemic diseases. Annales de Medecine Interne 144, 557-562.
23. FRASCI, G., IAFFAIOLI, R.V., COMELLA, G., COMELLA, P., SALZANO, F., GALIZIA, G., IMBRIANI, A., and PERSICO, G. (1994). Intraperitoneal adjuvant immunochemotherapy in operable gastric cancer with serous involvement. Clin. Oncol. 6, 364-370.
24. KLEINERMAN, E.S., CECCORULLI, L.M., BONVINI, E., ZICHT, R., and GALLIN, J.I. (1985). Lysis of tumor cells by human blood monocytes by a mechanism independent of the oxidative burst. Cancer Res. 45, 2058-2064.
25. ZWELLING, L.A., KERRIGAN, D., MICHAELS, S., and KOHN, K. (1982). Cooperative sequestration of m-AMSA in L1210 cells. Biochem. Pharmacol. 31, 3269-3277.
26. ZWELLING, L.A., HIND, M., CHAN, D., MAYER, J., SIE, K.L., SILBERMAN, L., RADCLIFFE, A., BERAN, M., and BLICK, M. (1989). Characterization of an amsacrine-resistant line of human leukemia cells: evidence for a drug-resistant form of topoisomerase II. J. Biol. Chem. 264, 16411-16420.
27. MIRSKI, S.L.E., EVANS, C.D., ALMQUIST, K.C., SLOVAK, M.L., and COLE, S.P.C. (1993). Altered topoisomerae IIα in a drug-resistant small cell lung cancr cell line selected in VP-16. Cancer Res. 53, 4866-4873.
28. FAN, D., CHAKRABARTY, S., SEID, C., BELL, C.W., SCHACKERT, H., MORIKAWA, K., and FIDLER, I.J. (1989). Clonal stimulation or inhibition of human colon carcinoma and hu- man renal carcinomas mediated by transforming growth factor-β 1. Cancer Commun. 12, 117-125.
29. BERENBAUM, M.C. (1981). Criteria for analyzing interaction between biologically active agents. Adv. Cancer Res. 35, 269-299.
30. ROSS, W., ROWE, T., GLISSON, B., YALOWICH, J., and LIU, O. (1984). Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Cancer Res. 44, 5857-5860.
31. DA VIES, W.M., ROBSON, C.N., DAVIES, S.L., and HICKSON, I.D. (1988). Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. J. Biol. Chem. 263, 17724-17729.
32. ESTEY, E., ADLAKHA, R.C., HITTLEMAN, W.N., and ZWELLING, L.A. (1987). Cell cycle stage dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity. Biochemistry 26, 4338-4344.
33. ZWELLING, L.A., ESTEY, E., SILBERMAN, L., DOYLE, S., and HITTLEMAN, W. (1987). Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated dna cleavage in human brain tumor cells and human fibroblasts. Cancer Res. 47, 251-257.